TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
LENZ

LENZ Therapeutics Inc

Healthcare · Biotechnology

3.90$ -2.5% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

LENZ Therapeutics Inc (LENZ) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 237 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LENZ
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
92 70 217 203 224 215 201 217 211 306 273 237
90 67 217 199 221 212 198 214 207 301 268 233
43 35 200 84 41 20 23 38 25 25 25 24
88 66 213 196 217 209 194 210 202 292 258 220
– – – – – 0.0 – – – 0.3 0.3 0.4
– – – – – 0.0 – – 0.9 2.9 3.5 4.1
162 163 19 9.7 8.7 11 9.2 11 17 22 26 17
17 19 19 8.6 7.7 10 8.6 10 16 21 26 17
0.1 0.1 0.4 0.6 0.6 0.6 0.5 0.5 0.5 0.5 0.4 –
5.1 5.7 7.1 4.4 2.8 4.3 3.7 2.9 4.3 4.2 11 6.6
-70 -93 198 193 215 204 192 206 194 284 246 219
-72 -95 -112 -122 -132 -145 -160 -175 -191 -227 -269 -301
8.2 8.3 4.7 26 27 27 28 28 29 31 31 31

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?